FridayJan 31, 2025 10:00 am

Study Reveals Insights into How Needed Treatments Can Bypass the Blood-Brain Barrier

A new study conducted by University of Liverpool scientists together with collaborators from around the world has revealed the most suitable ways through which the blood-brain barrier can be bypassed while treating neurological conditions. The blood-brain barrier has been a major challenge that has stood in the way of getting needed medicines into the brain, and this study’s findings offer solutions that could result in conditions like Alzheimer’s, Parkinson’s, epilepsy and brain tumors being treated effectively. The blood-brain barrier is a very selective shield protecting the brain from any harmful substances carried in blood. However, this protective feature has proven…

Continue Reading

FridayJan 31, 2025 10:00 am

Adageis Leveraging Data-Driven Solutions to Advance Value-Based Care and Drive Financial Performance

Adageis, with its AI-centric software ProActive Care Platform, supports healthcare providers in making the important shift toward effective value-based care models. Significantly, the company’s advanced patient healthcare data solutions are designed for seamless implementation across ACOs, CINs, and IPAs, integrating with existing electronic health records (“EHRs”) to identify high-risk patients and care gaps. The company helps providers navigate the financial incentives tied to value-based care by tracking performance metrics, as its Patented Risk Engine (“PRE”) enables proactive interventions, reducing costs and improving patient outcomes. Healthcare providers are under increasing pressure to transition from fee-for-service models to value-based care, where reimbursement…

Continue Reading

ThursdayJan 30, 2025 10:00 am

New Study to Explore the Link Between Sleep Disorder and Parkinson’s

Funded by the U.S. Department of Defense, a new study will be conducted to examine why individuals, especially veterans, who suffer from a certain sleep disorder often end up developing Parkinson’s disease. The DoD awarded $4 million to researchers at Oregon Health and Science University (OSHU), the VA Healthcare System at Portland, the VA Sound Healthcare System at Puget, and the University of Washington to conduct this study. The research aims to establish why most people who develop a sleep disorder that causes them to thrash in their sleep later develop Parkinson’s. The team wants to know why this happens…

Continue Reading

ThursdayJan 30, 2025 10:00 am

Adageis is at the Forefront of AI Implementation in Healthcare as Industry Shifts from General Intelligence to Targeted Impact, Tools Driving Higher Reimbursements

Healthcare is transitioning attention from general AI to targeted applications like patient risk assessment and workflow optimization to drive higher reimbursements. Adageis’s ProActive Care Platform addresses critical targeted areas like tracking revenue and performance from providing high-quality care. AI tools like Adageis’ patented Risk Engine enable proactive interventions, reducing costs and improving patient outcomes while increasing overall revenue. The company’s platform integrates seamlessly with major electronic health records (“EHR”) systems, in an easy-to-use app for providers. Artificial intelligence is reshaping healthcare, moving from ambitious goals of Artificial General Intelligence (“AGI”) to more targeted, high-impact applications. This transition aligns with the practical demands…

Continue Reading

TuesdayJan 28, 2025 10:45 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Is ‘One to Watch’

Proprietary R&D is led by a world-class team of medicinal chemists and industry veterans, ensuring innovative product development. A first-to-market product, unbuzzd addresses a fast-expanding consumer category, with 300% growth expected by 2030. Lucid-MS, a potential multi-billion-dollar asset, represents a significant breakthrough in the treatment of demyelinating diseases, supported by an expedited regulatory pathway. Strategic equity and royalty agreements with Celly Nutrition for consumer-focused alcohol misuse treatments provide an additional revenue stream. Quantum BioPharma is strategically positioned in two high-growth sectors: hangover remedies and MS therapeutics. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) is a biopharmaceutical company committed to developing innovative…

Continue Reading

TuesdayJan 28, 2025 10:00 am

How Technology Can Ease Medicare Enrollment

With the ever-increasing pace at which the healthcare landscape is evolving, digital tools are playing a bigger role in the enrollment for and selection of plans in Medicare. Phone consultations and traditional brochures are slowly being relegated as technology takes center stage. We explore how tech tools are helping qualifying individuals to enroll for and select appropriate coverage plans under Medicare. The Plan Finder at Medicare.gov This tool helps beneficiaries in their bid to compare different MA plans and the prescription drug plans available under Part D. A user is required to input their prescription medications, the doctors they prefer…

Continue Reading

FridayJan 24, 2025 10:00 am

US Announces Plan to Combat Parkinson’s Disease Across the Country

Last week, the National Institutes of Health announced that it had begun the process of implementing the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson's Act, with support from the Health and Human Services department. This legislation was signed into law on July 2nd, 2024, and directs that the Secretary of Health and Human Services conduct a project to prevent, diagnose, treat and cure Parkinson’s disease. Parkinson’s disease is a neurodegenerative illness that causes issues with movement, coordination and balance. Common symptoms include painful muscle contractions, tremors in one’s arms and legs, muscle stiffness, impaired coordination…

Continue Reading

ThursdayJan 23, 2025 10:45 am

Astiva Health Achieves 188% Membership Growth as It Strengthens Medicare Advantage Leadership

Astiva Health now serves more than 30,000 members, an increase that reflects the growing demand for the company’s unique, culturally aligned health care model. Astiva’s focus on multilingual support and tailored healthcare solutions are some of the key factors driving its success. The increase in membership comes as Astiva earned a prestigious 4-star CMS rating for 2025, placing it among the top-rated Medicare Advantage providers in California. The high CMS rating comes with up to $1,200 more per beneficiary annually compared to lower-rated plans. Astiva will use the increased funding to expand its offering with additional member benefits and to…

Continue Reading

ThursdayJan 23, 2025 10:00 am

New Trump Admin Could Drastically Change Research on Infectious Diseases

For decades now, the National Institutes of Health has funded a lot of research on illnesses and vaccines, allowing researchers to run different clinical trials and develop treatments to save millions of lives. Grants from this agency are awarded to almost every state, supporting thousands of jobs countrywide. In 2023, almost $5 billion of the agency’s budget was awarded to organizations outside the institute in America to advance careers in science as well as medicine. The National Institute of Allergy and Infectious Disease, a major division of this agency, has seen cures for hepatitis C being developed, a vaccine for…

Continue Reading

FridayJan 17, 2025 10:00 am

Autism: What You Need to Know

Autism spectrum disorder is a developmental and neurological disorder that influences how an individual communicates, interacts with others, behaves, and learns. Since the start of the new millennium, autism diagnoses have risen significantly, with data from the CDC showing that the autism rate in America as of 2022 was 2.77%. This is a significant increase from the 0.66% recorded in 2000. Estimates from WHO show that the global prevalence of the disorder stands at 1%, an increase from the 0.62% recorded over a decade ago. Researchers attribute the increase in diagnoses to more screening. The inclusion of a range of…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000